INTRODUCTION {#s1}
============

Gallbladder cancer (GBC) is the most common biliary tract neoplasm worldwide and is a rare but a fatal malignancy characterized by poor prognosis and absence of effective therapy \[[@R1]\]. Surgery is the only definitively curative treatment \[[@R2]\]. However, even after operation, the rate of locoregional recurrence is high. It has considerable wide geographic and ethnic variation with distinctive pockets of high incidence in Eastern and Central Europe, South and Central America, South Asia, and Japan \[[@R3], [@R4]\].

Recent literature has demonstrated that marital status is an independent prognostic factor for survival in many cancers \[[@R5]--[@R8]\]. Wang et al. reported that marital status was an important risk predictor in pancreatic cancer and that widowed patients were at the highest risk for cancer-specific mortality \[[@R7]\]. Li et al. found that widowed patients with colorectal cancer were at highest risk for death compared with other groups \[[@R8]\]. Few study explored the effect of marital status on GBC survival. Therefore, this study aimed to investigate the relationship between marital status and GBC survival. We selected data from the Surveillance, Epidemiology, and End Results (SEER) cancer registry to study the effect of marital status on GBC cause-specific survival (GCSS) in patients with GBC treated by surgical resection.

RESULTS {#s2}
=======

Baseline patient characteristics {#s2_1}
--------------------------------

The present study identified 9,041 eligible patients during the 25-year study period (between 1988 and 2013), including 2,453 male and 6,588 female patients. Of these, 2,549 (28.2%) were widowed, 4,632 (51.2%) were married, 1,093 (12.1%) had never married, and 767 (8.5%) were divorced/separated. Within group comparisons, the widowed group had the higher proportion of women (90.4%), white race(81.4%), older (≥ 60 years) patients (96.2%), adenocarcinoma (91.1%), and tumors at well/moderate pathological grading (50.9%) and at localized SEER stage (48.5%), all of which were statistically significant (*P* \< 0.001). Table [1](#T1){ref-type="table"} showed the baseline patient demographics and tumor characteristics.

###### Baseline demographic and tumor characteristics of gallbladder cancer patients in the SEER database

  Characteristic            Total         Widowed       Married       Never married   Divorced/separated   *P*
  ------------------------- ------------- ------------- ------------- --------------- -------------------- ----------
  Sex                                                                                                      \< 0.001
  Male                      2453 (27.1)   245 (9.6)     1760 (38.0)   283 (25.9)      165 (21.5)           
  Female                    6588 (72.9)   2304 (90.4)   2872 (62.0)   810 (74.1)      602 (78.5)           
  Age                                                                                                      \< 0.001
  \< 60                     1917 (21.2)   96 (3.8)      1171 (25.3)   406 (37.1)      244 (31.8)           
  ≥ 60                      7124 (78.8)   2453 (96.2)   3461 (74.7)   687 (62.9)      523 (68.2)           
  Race                                                                                                     \< 0.001
  White                     7154 (79.1)   2074 (81.4)   3664 (79.1)   812 (74.3)      604 (78.7)           
  Black                     844 (9.3)     203 (8.0)     324 (7.0)     197 (18.0)      120 (15.6)           
  Other\*                   1043 (11.5)   272 (10.7)    644 (13.9)    84 (7.7)        43 (5.6)             
  Year of diagnosi^s^†                                                                                     \< 0.001
  1988--1996                1832 (20.3)   637 (25.0)    928 (20.0)    153 (14.0)      114 (14.9)           
  1997--2005                3459 (38.3)   1002 (39.3)   1765 (38.1)   393 (36.0)      299 (39.0)           
  2006--2013                3750 (41.5)   910 (35.7)    1939 (41.9)   547 (50.0)      354 (46.2)           
  Histotype                                                                                                0.027
  Adenocarcinoma            8135 (90.0)   2323 (91.1)   4149 (89.6)   984 (90.0)      679 (88.5)           
  Squamous cell carcinoma   93 (1.0)      32 (1.3)      43 (0.9)      10 (0.9)        8 (1.0)              
  Adenosquamous carcinoma   276 (3.1)     73 (2.9)      151 (3.3)     35 (3.2)        17 (2.2)             
  Other^\#^                 537 (5.9)     121 (4.7)     289 (6.2)     64 (5.9)        63 (8.2)             
  Pathological grading                                                                                     0.354
  Well/moderate             4632 (51.2)   1297 (50.9)   2385 (51.5)   583 (53.3)      367 (47.8)           
  Poor/anaplastic           3498 (38.7)   992 (38.9)    1774 (38.3)   409 (37.4)      323 (42.1)           
  Unknown                   911 (10.1)    260 (10.2)    473 (10.2)    101 (9.2)       77 (10.0)            
  TNM stage                                                                                                \< 0.001
  I/II                      768 (8.5)     211 (8.3)     369 (8.0)     126 (11.5)      62 (8.1)             
  III/IV                    1072 (11.9)   232 (9.1)     579 (12.5)    156 (14.3)      105 (13.7)           
  Unknown                   7201 (79.6)   2106 (82.6)   3684 (79.5)   811 (74.2)      600 (78.2)           
  Tumor size                                                                                               
  \< 3 cm                   1356 (15.0)   331 (13.0)    708 (15.3)    192 (17.6)      125 (16.3)           \< 0.001
  3--5 cm                   891 (9.9)     232 (9.1)     450 (9.7)     108 (9.9)       101 (13.2)           
  \> 5 cm                   524 (5.8)     125 (4.9)     268 (5.8)     81 (7.4)        50 (6.5)             
  Not stated                6270 (69.4)   1861 (73.0)   3206 (69.2)   712 (65.1)      491 (64.0)           
  SEER stage                                                                                               \< 0.001
  Localized                 3994 (44.2)   1236 (48.5)   1951 (42.1)   502 (45.9)      305 (39.8)           
  Regional                  2564 (28.4)   715 (28.1)    1328 (28.7)   294 (26.9)      227 (29.6)           
  Distant                   2386 (26.4)   576 (22.6)    1297 (28.0)   284 (26.0)      229 (29.9)           
  Unstaged                  97 (1.1)      22 (0.9)      56 (1.2)      13 (1.2)        6 (0.8)              

Abbreviations: SEER, Surveillance, Epidemiology, and End Results.

\*Other includes American Indian/Alaska native, Asian/Pacific Islander, and unknown.

^†^The early and middle Year of diagnosis were all lasted nine years, the latter was lasted eight years

^\#^Other cancers includes signet ring, small cell, giant and spindle cell, non-small cell carcinoma, carcinoma not otherwise specified, or undifferentiated carcinoma.

Effect of marital status on GCSS {#s2_2}
--------------------------------

The married group had higher 5-year GCSS than that of the unmarried patients (21.1% vs. 16.1%, *P* \< 0.001) (Figure [1](#F1){ref-type="fig"}). The 5-year GCSS was 13.9% in the widowed group, which was the lowest compared with that in the married group (21.1%), in the never married group (20.2%), and in the divorced/separated group (18.7%); all differences were significant according to the univariate log rank test (all *P* \< 0.001) (Figure [2A](#F2){ref-type="fig"}). Black race (*P* \< 0.001), older age (*P* \< 0.001), early year of diagnosis (1988--1996) (*P* \< 0.001), adenosquamous carcinoma (*P* \< 0.001), poor or undifferentiated pathology grade (*P* \< 0.001), tumor size \>5 cm (*P* \< 0.001), TNM stage III/IV disease (*P* \< 0.001), SEER distant stage (*P* \< 0.001), and the widowed group (*P* \< 0.001) were found as significant risk predictor for poor survival on univariate analysis (Table [2](#T2){ref-type="table"}). When multivariate survival analysis was performed, all the aforementioned variables were validated as independent risk predictors associated with poor survival (Table [2](#T2){ref-type="table"}), as follows: age (≥ 60 years, hazard ratio \[HR\] 1.521, 95% confidence interval \[CI\] 1.429--1.618), race (black, HR 1.055, 95% CI 0.973--1.144; other races, HR 0.917, 95% CI 0.855--0.994), year of diagnosis (1997--2005, HR 0.930, 95% CI 0.875--0.988; 2006--2013, HR 0.854, 95% CI 0.789--0.923), histotype (squamous cell carcinoma, HR 1.551, 95% CI 1.241--1.937, adenosquamous carcinoma, HR 1.211, 95% CI 1.064--1.378, other, HR 1.109, 95% CI 1.004--1.225), pathology grade (poor or undifferentiated tumor, HR 1.499, 95% CI 1.424--1.578, unknown pathology grade, HR 0.998, 95% CI 0.919--1.085), TNM stage (stage III/IV, HR 1.137, 95% CI 0.972--1.329; unknown stage, HR 1.259, 95% CI 1.091--1.452), tumor size (3--5 cm tumor, HR 1.123, 95% CI 1.008--1.250; \>5 cm tumor, HR 1.184, 95% CI 1.044--1.344; unstated tumor size, HR 1.415, 95% CI 1.301--1.539), SEER stage (regional stage, HR 1.956, 95% CI 1.842--2.077; distant stage, HR 3.370, 95% CI 3.160--3.594; unstaged, HR 1.719, 95% CI 1.382--2.139), marital status (married, HR 0.774, 95% CI 0.732--0.817; never married, HR 0.914, 95% CI 0.842--0.994; divorced/separated, HR 0.891, 95% CI 0.813--0.977).

![Survival curves in gallbladder cancer patients treated with surgical resection between the unmarried patients and the married patients\
χ^2^ = 74.829, *P* \< 0.001.](oncotarget-08-26404-g001){#F1}

![Survival curves in gallbladder cancer patients treated with surgical resection according to marital status\
(**A**) Overall: χ^2^ = 113.429, *P* \< 0.001; (**B**) Well/moderate: χ^2^ = 69.264, *P* \< 0.001; (**C**) Poor/anaplastic: χ^2^ = 37.754, *P* \< 0.001; (**D**) Localized: χ^2^ = 124.013, *P* \< 0.001; (**E**) Regional: χ2 = 29.216, *P* \< 0.001; (**F**) Distant: χ^2^ = 68.705, *P* \< 0.001.](oncotarget-08-26404-g002){#F2}

###### Univariate and multivariate survival analysis for evaluating the influence of marital status on gallbladder cancer cause-specific survival in SEER database

  Variable                  Total   5-year CCS   Univariate analysis   Multivariate analysis                          
  ------------------------- ------- ------------ --------------------- ----------------------- ---------------------- ----------
  Sex                                            1.770                 0.183                                          NI
  Male                      2453    17.6%                                                                             
  Female                    6588    19.1%                                                                             
  Age                                            148.198               \< 0.001                                       \< 0.001
  \< 60                     1917    26.5%                                                      Reference              
  ≥ 60                      7124    16.7%                                                      1.521 (1.429--1.618)   
  Race                                           19.846                \< 0.001                                       0.032
  White                     7154    18.2%                                                      Reference              
  Black                     844     16.9%                                                      1.055 (0.973--1.144)   0.191
  Other\*                   1043    23.8%                                                      0.917 (0.855--0.994)   0.034
  Year of diagnosis^†^                           107.566               \< 0.001                                       \< 0.001
  1988--1996                1832    15.5%                                                      Reference              
  1997--2005                3459    17.0%                                                      0.930 (0.875--0.988)   0.019
  2006--2013                3750    22.4%                                                      0.854 (0.789--0.923)   \< 0.001
  Histotype                                      85.488                \< 0.001                                       \< 0.001
  Adenocarcinoma            8135    19.3%                                                      Reference              
  Squamous cell carcinoma   93      11.9%                                                      1.551 (1.241--1.937)   \< 0.001
  Adenosquamous carcinoma   276     8.1%                                                       1.211 (1.064--1.378)   0.004
  Other^\#^                 537     16.0%                                                      1.109 (1.004--1.225)   0.042
  Pathological grading                           649.023               \< 0.001                                       \< 0.001
  Well/moderate             4632    24.6%                                                      Reference              
  Poor/anaplastic           3498    9.7%                                                       1.499 (1.424--1.578)   \< 0.001
  Unknown                   911     23.4%                                                      0.998 (0.919--1.085)   0.970
  TNM stage                                      251.771               \< 0.001                                       0.002
  I/II                      768     52.1%^††^                                                  Reference              
  III/IV                    1072    15.3%^††^                                                  1.137 (0.972--1.329)   0.109
  Unknown                   7201    23.7%^††^                                                  1.259 (1.091--1.452)   0.002
  Tumor size                                     226.873               \< 0.001                                       \< 0.001
  \< 3 cm                   1356    32.7%                                                      Reference              
  3--5 cm                   891     21.7%                                                      1.123 (1.008--1.250)   0.034
  \> 5 cm                   524     16.5%                                                      1.184 (1.044--1.344)   0.009
  Not stated                6270    16.0%                                                      1.415 (1.301--1.539)   \< 0.001
  SEER stage                                     1911.283              \< 0.001                                       \< 0.001
  Localized                 3994    33.4%                                                      Reference              
  Regional                  2564    9.7%                                                       1.956 (1.842--2.077)   \< 0.001
  Distant                   2386    3.7%                                                       3.370 (3.160--3.594)   \< 0.001
  Unstaged                  97      12.2%                                                      1.719 (1.382--2.139)   \< 0.001
  Marital status                                 105.116               \< 0.001                                       \< 0.001
  Widowed                   2549    13.9%                                                      Reference              
  Married                   4632    21.1%                                                      0.774 (0.732--0.817)   \< 0.001
  Never married             1093    20.2%                                                      0.914 (0.842--0.994)   0.035
  Divorced/separated        767     18.7%                                                      0.891 (0.813--0.977)   0.014

Abbreviations: SEER, Surveillance, Epidemiology, and End Results; CCS, cause-specific survival.

\*Other includes American Indian/Alaska native, Asian/Pacific Islander, and unknown.

^†^The early and middle Year of diagnosis were all lasted nine years, the latter was lasted eight years

^\#^Other cancers includes signet ring, small cell, giant and spindle cell, non-small cell carcinoma, carcinoma not otherwise specified, or undifferentiated carcinoma.

^††^3-year CCS. Because TNM stage record according to the AJCC Cancer Staging Manual (7th edition) in the SEER database began from 2009, and ended at 2013, its 5-year CCS did not exist.

NI: not included in the multivariate survival analysis.

Subgroup analysis of pathological grading {#s2_3}
-----------------------------------------

We further analyzed the effects of marital status on survival in tumors of different pathological gradings. There were no significant differences in the subgroup of pathological gradings among the different marital status groups (Table [1](#T1){ref-type="table"}), and we observed two interesting findings. On the one hand, pathological grading was an independent factor for poor survival, both in the univariate and multivariate analysis (*P* \< 0.001). On the other hand, widowed patients had the lowest survival rate in comparisons at all pathological grading: For well/moderate pathological grading tumors, 5-year GCSS of widowed patients had 9.8%, 10%, and 6.4% reductions compared with that of married patients, never married patients, and divorced/separated patients respectively (all *P* \< 0.01). For poor/anaplastic pathological grading tumors, widowed patients had a 3.9% reduction in 5-year GCSS compared with married patients (*P* \< 0.001), a 2.3% reduction in 5-year GCSS compared with never married patients (*P* = 0.064), and a 4.2% reduction in 5-year GCSS compared with divorced/separated patients (*P* = 0.005). (Table [3](#T3){ref-type="table"}, and Figure [2B--2C](#F2){ref-type="fig"}).

###### Univariate and multivariate analysis of marital status on gallbladder cancer cause-specific survival based on different pathological grading

  Variable                   Total   5-year CCS   Univariate analysis   Multivariate analysis                          
  -------------------------- ------- ------------ --------------------- ----------------------- ---------------------- ----------
  **Pathological grading**                                                                                             
  **Well/moderate**          4632                                                                                      
  **Marital status**                              69.264                \< 0.001                                       \< 0.001
  Widowed                    1297    17.9%        Reference                                     Reference              
  Married                    2385    27.7%        68.612                \< 0.001                0.727 (0.674--0.786)   \< 0.001
  Never married              583     27.9%        18.276                \< 0.001                0.780 (0.695--0.877)   \< 0.001
  Divorced/separated         367     24.3%        7.422                 0.006                   0.832 (0.728--0.951)   0.007
  **Poor/anaplastic**        3498                                                                                      
  **Marital status**                              37.754                \< 0.001                                       \< 0.001
  Widowed                    992     7.1%         Reference                                     Reference              
  Married                    1774    11.0%        37.118                \< 0.001                0.784 (0.722--0.851)   \< 0.001
  Never married              409     9.4%         3.437                 0.064                   0.891 (0.788--1.008)   0.067
  Divorced/separated         323     11.3%        7.772                 0.005                   0.827 (0.723--0.946)   0.006

Abbreviations: CCS, cause-specific survival.

Subgroup analysis of SEER stage {#s2_4}
-------------------------------

We also analyzed the effects of marital status on survival at each SEER stage. Again, we had two interesting findings. On the one hand, marital status was an independent risk factor for poor survival in patients with each SEER stage disease, both in the univariate and multivariate analysis (*P* \< 0.001). On the other hand, widowed patients again had the lowest survival rate in comparisons at all SEER stages: For localized stage tumors, widowed patients had a 15.9% reduction in 5-year GCSS compared with married patients (23.5% vs. 39.4%) (*P* \< 0.001), a 10.1% reduction in 5-year GCSS compared with never married patients (23.5% vs. 33.6%) (*P* \< 0.001), and a 12.6% reduction in 5-year GCSS compared with divorced/separated patients (23.5% vs. 36.1%) (*P* \< 0.001). For regional stage tumors, widowed patients had a 4.2% reduction in 5-year GCSS compared with married patients (6.7% vs. 10.9%) (*P* \< 0.001), a 5.9% reduction in 5-year GCSS compared with never married patients (6.7% vs. 12.6%) (*P* = 0.010), and an 3.1% reduction in 5-year GCSS compared with divorced/separated patients (6.7% vs. 9.8%) (*P* = 0.015) (Table [4](#T4){ref-type="table"}, and Figure [2D--2F](#F2){ref-type="fig"}).

###### Univariate and multivariate analysis of marital status on gallbladder cancer cause-specific survival based on different SEER stage

  Variable             Total   5-year CCS   Univariate analysis   Multivariate analysis                          
  -------------------- ------- ------------ --------------------- ----------------------- ---------------------- ----------
  **SEER stage**                                                                                                 
  **Localized**        3994                                                                                      
  **Marital status**                        124.013               \< 0.001                                       \< 0.001
  Widowed              1236    23.5%        Reference                                     Reference              
  Married              1951    39.4%        124.908               \< 0.001                0.625 (0.575--0.681)   \< 0.001
  Never married        502     33.6%        16.809                \< 0.001                0.771 (0.679--0.876)   \< 0.001
  Divorced/separated   305     36.1%        19.570                \< 0.001                0.712 (0.611--0.830)   \< 0.001
  **Regional**         2564                                                                                      
  **Marital status**                        29.216                \< 0.001                                       \< 0.001
  Widowed              715     6.7%         Reference                                     Reference              
  Married              1328    10.9%        29.036                \< 0.001                0.775 (0.704--0.853)   \< 0.001
  Never married        294     12.6%        6.633                 0.010                   0.822 (0.709--0.953)   0.009
  Divorced/separated   227     9.8%         5.954                 0.015                   0.817 (0.696--0.959)   0.013
  **Distant**          2386                                                                                      
  **Marital status**                        68.705                \< 0.001                                       \< 0.001
  Widowed              576     1.9%         Reference                                     Reference              
  Married              1297    4.4%         68.102                \< 0.001                0.669 (0.604--0.741)   \< 0.001
  Never married        284     4.2%         19.727                \< 0.001                0.716 (0.616--0.831)   \< 0.001
  Divorced/separated   229     4.1%         13.733                \< 0.001                0.749 (0.639--0.879)   \< 0.001

Abbreviations: SEER, Surveillance, Epidemiology, and End Results; CCS, cause-specific survival.

DISCUSSION {#s3}
==========

Some studies have suggested married patients have longer overall survival and lower mortality than those who have never married, separated, widowed, or divorced for many important causes of death respectively \[[@R13]--[@R15]\]. By using the SEER database to determine the relationship between marital status and survival, the present study showed that married patients had significantly better GCSS than their unmarried counterparts. Widowed patients had the lowest GCSS compared with all other patients. Moreover, in multivariable analyses, the risk for widowed patients lasted even after adjusting for age, race, year of diagnosis, histologic type, pathological grading, tumor size, TNM stage,and SEER stage.

One hypothesis for the bad prognosis in unmarried individuals has delayed diagnosis with advanced tumor stage; however, in this study group, Table [1](#T1){ref-type="table"} showed the percentages of patients with well/moderate and poor/anaplastic pathological gradings were comparable among the four subgroups. Moreover, widowed patients had the highest rate of well/moderate pathological grading. Widowed patients had worse 5-year GCSS (17.9%) compared with married (27.7%), never married (27.9%), and divorced/separated (24.3%) patients (all *P* \< 0.01). Similarly, among the patients with poor/anaplastic pathological grading, the widowed group had worse 5-year LCSS (7.1%) compared with married (11.0%) and divorced/separated (11.3%) patients (all *P* \< 0.01). Notably, at poor/anaplastic pathological grading, there was no significant difference in GCSS between the widowed group and never married (7.1% vs. 9.4%, *P* = 0.064)---this is a result of smaller sample size.

Psychosocial factors may provide a reasonable explanation for the relationship between marital status and survival. Although psychosocial factors are regarded as an independent reason, considered separately from tumor biological characteristics and extent of treatment, these may play several important roles associated with cancer progress. Unmarried and especially widowed patients may suffer from a lack of emotional support and social attention (otherwise provided by a spouse), which contributes to more distress, depression, and anxiety than that experienced by their married counterparts \[[@R16]\]. Also, a cancer diagnosis can lead to distress \[[@R17]\]. In widowed patients, increased mortality rates may be due to the inability to relieve stress and the loss of social attention \[[@R18]\].

Furthermore, the level of adherence to the treatment plan may be different due to marital status. Compared with unmarried patients, married patients were inclined to be more likely to comply with treatment \[[@R19]\]; conversely, unrecognized clinical depression may lead to poor adherence to medical treatment and, further, that married patients showed a lower risk of major depression \[[@R20]\].

There is some evidence that the level of physiological stress and depression may affect cancer outcomes via different mechanisms. Increased psychological stress and decreased psychosocial support may contribute to weakened immune function and, in this way, may lead to tumor progression and mortality \[[@R21]--[@R23]\]. Reportedly, two meta-analyses showed that depression increased cancer mortality by 19% and 39%, respectively \[[@R24], [@R25]\]. Furthermore, perceived lack of social support has been proven to destroy the activity of natural killer cells \[[@R26]\]. Also, chronic stress may contribute to downregulated cortisol receptors in white blood cells \[[@R27]\]. This downregulation also degrades the cellular response to anti-inflammatory signals and accelerates cytokine-mediated inflammatory processes \[[@R28]\], which, in colorectal cancer, has been regarded as a poor prognostic factor \[[@R29], [@R30]\]. Additionally, a previous study reported that some other neuroendocrine mediators and cytokines present in depression, and stress had been associated with cancer metastasis \[[@R23]\]. Finally, depression and poor quality of life may lead to an increased level of vascular endothelial growth, which may promote endothelial cell migration, proliferation, and proteolytic activity \[[@R31]\].

The present study investigated SEER data to evaluate the relationship between marital status and the postoperative prognosis of GBC; however, the study had some potential limitations. First, the SEER database only provided marital status at diagnosis. Marital status may have changed for some patients during the therapeutic process, and these changes may have affected the outcomes. Second, some data of marital status may have been inexhaustive---for example; some married patients may have separated, while other never married patients may have been cohabitating. Third, the quality of a marriage can also affect the survival of GBC patients. Marital distress has also been associated with long-term immune consequences and has contributed to an elevated risk of various health problems \[[@R32]\]. Finally, the SEER GBC database lacks quality data on adjuvant therapy, comorbidities, and recurrence.

To our best knowledge, this is the first report studying the effect of marital status on the survival of GBC patients treated with surgical resection. Despite these potential limitations, our study confirmed that unmarried patients are at greater risk for cancer-specific mortality. Furthermore, we showed that widowed patients were always at the highest risk for death via cancer. Psychosocial factors may be the primary reasons leading to poor survival in unmarried patients. Therefore, to improve postoperative survival, physicians should take into consideration social supports during their care of unmarried patients with GBC and especially of widowed patients. Further clinical trials should be performed to confirm our hypothesis.

Statistical analysis {#s3_1}
--------------------

We analyzed sex, age, race, primary tumor site, histologic type, pathology grade, tumor size, TNM stage, SEER stage, survival months, vital status, and marital status at the time of diagnosis. The TNM stage according to the criteria described at the American Joint Committee on Cancer (AJCC) Cancer Staging Manual (7th edition) was established. We categorized patients as "never married," "married," "widowed," or "separated/divorced." "Unmarried" included "never married," "widowed," and "separated/divorced." The individuals who were separated and who were divorced were grouped together in the group in our study.

The primary focus of this study was GCSS, which was obtained from the date of diagnosis of gallbladder cancer and the date of gallbladder cancer cause-specific death. Deaths attributed to GBC were treated as events, and deaths from other causes were treated as censored observations.

The baseline patient demographics and tumor characteristics were analyzed using the chi-square test. Death rate of the GBC was evaluated between groups using the Kaplan--Meier method. Risk factors for survival outcome were assessed using multivariable Cox regression models. All statistical analyses were performed using the statistical software package SPSS 22.0 software (IBM Corp, Armonk, NJ, USA). A *P* value \< 0.050 was considered statistically significant.

MATERIALS AND METHODS {#s4}
=====================

Baseline patient characteristics {#s4_1}
--------------------------------

The SEER program of the National Cancer Institute is an authoritative source of information on cancer incidence and survival in the United States. The SEER program registries routinely collect patient clinical data including demographics, the tumor morphology and stage at diagnosis, first course of treatment, the follow-up for survival, and so on. SEER currently collects and publishes cancer incidence and survival data from 18 population-based cancer registries that represent approximately 30% of the population in the United States.

SEER data contain no identifiers and have been widely used for studies of the relationship between marital status and survival outcome in patients with cancer \[[@R5],[@R6],[@R9]--[@R12]\]. We used SEER\*Stat 8.1.5 software to identify patients with a histopathologic diagnosis of GBC between 1988 and 2013. SEER registry patients eligible for this cohort included those with the following histologic type ICD-O-3: adenocarcinoma (8140, 8141, 8143, 8147), papillary adenocarcinoma (8260, 8261, 8262, 8263), mucinous adenocarcinoma (8480, 8481), adenocarcinoma with metaplasia (8571, 8572, 8573, 8574, 8575, 8576), papillary carcinoma (8050, 8051, 8052), duct carcinoma (8500, 8501, 8503, 8504, 8507, 8508), squamous cell carcinoma (8070, 8071, 8072, 8073, 8074, 8075, 8076, 8078), adenosquamous carcinoma (8560, 8562), or other cancers, including signet ring (8490), small cell (8041, 8043), giant and spindle cell (8030--8035), non-small cell carcinoma (8046), carcinoma not otherwise specified (8010, 8011, 8012, 8013, 8014, 8015), or undifferentiated carcinoma (8020, 8021, 8022). Patients with any other histologic type were excluded from analysis.

We excluded patients who were less than 18 years at diagnosis; did not undergo surgical resection for GBC; had multiple primary cancers, of which the GBC was not the first; and who had an unknown cause of death or unknown survival length.

According to the SEER staging system, tumors that remained *in situ* or confined to the organ of origin were considered to be localized; tumors that invaded locally or metastasized to regional lymph nodes were regarded as regional, while those that traveled to distant organs were considered to be distant.
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